LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in KRAS-Mutant Lung Adenocarcinoma-Reference-Cited by-同舟云学术

LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in KRAS-Mutant Lung Adenocarcinoma

Published:2019-04-30 Issue:13 Volume:79 Page:3251-3267
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Galan-Cobo Ana,Sitthideatphaiboon Piyada,Qu Xiao,Poteete Alissa,Pisegna Marlese A.,Tong Pan,Chen Pei-Hsuan,Boroughs Lindsey K.,Rodriguez Mirna L.M.,Zhang Winter,Parlati Francesco,Wang Jing,Gandhi Varsha,Skoulidis Ferdinandos,DeBerardinis Ralph J.,Minna John D.^ORCID,Heymach John V.^ORCID

Funder

HHS | NIH | National Cancer InstituteHHS | NIH | National Cancer Institute (NCI)

HHS | NIH | National Center for Research ResourcesHHS | NIH | National Center for Research Resources (NCRR)

Cancer Prevention and Research Institute of TexasCancer Prevention and Research Institute of Texas (CPRIT)

American Association for Cancer ResearchAmerican Association for Cancer Research (AACR)

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 208 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nrf2 pathways in neuroprotection: Alleviating mitochondrial dysfunction and cognitive impairment in aging;Life Sciences;2024-09

2. The unique catalytic properties of PSAT1 mediate metabolic adaptation to glutamine blockade;Nature Metabolism;2024-08-27

3. A Core NRF2 Gene Set Defined Through Comprehensive Transcriptomic Analysis Predicts Selective Drug Resistance and Poor Multicancer Prognosis;Antioxidants & Redox Signaling;2024-08-08

4. Cyclopeptide RA-V from Rubia yunnanensis restores activity of Adagrasib against colorectal cancer by reducing the expression of Nrf2;Pharmacological Research;2024-08

5. Loss of STK11 Suppresses Lipid Metabolism and Attenuates KRAS-Induced Immunogenicity in Patients with Non–Small Cell Lung Cancer;Cancer Research Communications;2024-08-01